Pharmaceutical Supply and Fulfillment

This contract involves the supply of Atropine Sulfate Injection, USP, ensuring compliance with FDA regulations, current Good Manufacturing Practices (cGMP), and Defense Logistics Agency (DLA) labeling standards. The scope includes proper packaging and complete documentation to facilitate federal delivery, supporting the pharmaceutical needs within the Department of Defense. The solicitation, titled "Pharmaceutical Supply and Fulfillment," is a subcontract opportunity with a response deadline set for June 3, 2026. The contract pertains to the pharmaceutical manufacturing sector under NAICS code 325412. The solicitation was posted by the Defense Logistics Agency, a component of the Department of Defense, on May 28, 2026. While specific location details and points of contact are not provided, interested subcontractors can access additional information and submit responses through the DLA's contracting portal. This contract ensures the reliable provision of a critical medical product for defense-related healthcare requirements.